A phase-by-phase framework covering CPOM compliance, malpractice exposure, physician retention, and revenue sustainability for lower middle market aesthetic practice acquisitions.
Find Cosmetic Surgery Center Acquisition TargetsAcquiring a cosmetic surgery center offers access to high-margin elective procedures and recurring non-surgical revenue, but requires specialized diligence. Key risks include physician key-man dependency, corporate practice of medicine restrictions, malpractice tail liability, and staff retention. A structured three-phase process helps buyers validate financials, assess regulatory compliance, and confirm revenue durability before closing.
Confirm that reported revenue is real, recurring, and transferable without the selling physician. Identify procedure mix concentration and assess EBITDA quality before proceeding.
Separate surgical revenue from non-surgical repeat treatments. Practices with 40%+ revenue from injectables and laser services show stronger post-acquisition revenue durability.
Quantify how much revenue is personally generated by the selling surgeon versus associate physicians, NPs, or injectors. Key-man concentration above 80% materially reduces transferable value.
Recast financials to remove owner compensation above market rate, personal vehicle costs, and discretionary spending embedded in the P&L to establish true EBITDA.
Evaluate healthcare regulatory compliance, malpractice exposure, and corporate structure before finalizing deal terms. Regulatory defects can kill financing and close options.
Confirm the practice operates through a compliant PC/MSO structure in the target state. Non-compliant fee-splitting arrangements can invalidate the acquisition and trigger regulatory penalties.
Pull five years of claims history, review open litigation, and confirm whether tail insurance obligations transfer to buyer or remain with the seller post-closing.
Verify AAAHC or Joint Commission accreditation status, all state facility licenses, and DEA registrations are current and confirm transferability to the new ownership entity.
Assess staff retention likelihood, patient relationship transferability, and the seller's transition commitment to ensure post-close revenue continuity.
Review contracts for lead injectors, aesthetic nurses, and surgical coordinators. High-producing staff without non-solicitation agreements represent significant post-close revenue risk.
Audit the EMR for active patient count, return visit frequency, and HIPAA-compliant consent language that permits outreach under new ownership.
Negotiate a physician transition period of 12–24 months with geographic and duration non-compete provisions that protect the acquired patient relationships and referral network.
Verify the Cosmetic Surgery Center acquisition qualifies for SBA financing, the purchase price is supportable by the verified cash flow, and the deal structure protects the buyer's downside.
Confirm the Cosmetic Surgery Center meets SBA 7(a) eligibility requirements: the business is for-profit, U.S.-based, within SBA size standards, and the buyer meets personal financial requirements. Some industries have specific SBA restrictions — verify before LOI.
Model verified normalized EBITDA against projected SBA loan payments at current rates. A $1M SBA 7(a) loan at 10.5% over 10 years costs approximately $13,000/month. The Cosmetic Surgery Center must generate at least 1.25x debt service coverage after a market-rate manager salary to pass underwriting.
Confirm the seller note is properly subordinated to the SBA loan and goes on 24-month standby as required by SBA rules. If an earnout is included, define exact measurement metrics, time period, and dispute resolution process before signing the purchase agreement.
Before signing a Letter of Intent, request these documents from the seller. Missing or incomplete items are a red flag — not a reason to proceed without them.
Yes, through an MSO structure that separates the business entity from the licensed professional corporation. The physician remains the PC owner while the buyer controls the management company and economics. State-specific CPOM laws govern permissible structures.
Expect 3.5x–6x EBITDA for lower middle market centers. Higher multiples reflect diversified procedure mix, low physician key-man risk, accredited facilities, and strong recurring non-surgical revenue with documented patient retention.
Yes, SBA 7(a) loans are commonly used and cosmetic surgery centers are SBA-eligible. Most deals combine an SBA loan covering 70–80% of the purchase price with a seller note, contingent on a physician transition period post-close.
Require a negotiated non-compete agreement covering a defined geographic radius and minimum two-year term. Pair this with a transition service agreement that keeps the seller engaged clinically, reducing incentive to depart and protecting referral relationships.
More Cosmetic Surgery Center Guides
DealFlow OS surfaces targets with seller signals and motivation scores — so you know before you start diligence. Free to join.
Start finding deals — freeNo credit card required
For Buyers
For Sellers